Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Outcome and Prognostic Factors for RA Patients With Interstitial Lung Disease

NCT03099525 is registered in ClinicalTrials.gov with Hanyang University as lead sponsor.

NCT NCT03099525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03099525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Outcome and Prognostic Factors for RA Patients With Interstitial Lung Disease
Lead sponsor
Hanyang University
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2016
Completion date
March 31, 2022
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, rheumatoid arthritis